Royal Bank of Canada’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.01M | Buy |
99,899
+95,065
| +1,967% | +$965K | ﹤0.01% | 3573 |
|
|
2025
Q1 | $27K | Sell |
4,834
-2,913
| -38% | -$16.3K | ﹤0.01% | 5432 |
|
|
2024
Q4 | $63K | Buy |
7,747
+823
| +12% | +$6.69K | ﹤0.01% | 5098 |
|
|
2024
Q3 | $71K | Buy |
6,924
+633
| +10% | +$6.49K | ﹤0.01% | 5077 |
|
|
2024
Q2 | $45K | Buy |
6,291
+4,908
| +355% | +$35.1K | ﹤0.01% | 5317 |
|
|
2024
Q1 | $19K | Sell |
1,383
-10,143
| -88% | -$139K | ﹤0.01% | 5500 |
|
|
2023
Q4 | $106K | Buy |
11,526
+4,972
| +76% | +$45.7K | ﹤0.01% | 5064 |
|
|
2023
Q3 | $40K | Buy |
6,554
+2,483
| +61% | +$15.2K | ﹤0.01% | 5407 |
|
|
2023
Q2 | $32K | Buy |
4,071
+4,065
| +67,750% | +$32K | ﹤0.01% | 5525 |
|
|
2023
Q1 | $0 | Sell |
6
-185
| -97% | – | ﹤0.01% | 6849 |
|
|
2022
Q4 | $1K | Sell |
191
-896
| -82% | -$4.69K | ﹤0.01% | 6584 |
|
|
2022
Q3 | $3K | Buy |
1,087
+570
| +110% | +$1.57K | ﹤0.01% | 6418 |
|
|
2022
Q2 | $2K | Sell |
517
-3,425
| -87% | -$13.3K | ﹤0.01% | 6513 |
|
|
2022
Q1 | $21K | Sell |
3,942
-2,157
| -35% | -$11.5K | ﹤0.01% | 6095 |
|
|
2021
Q4 | $90K | Buy |
6,099
+2,729
| +81% | +$40.3K | ﹤0.01% | 5489 |
|
|
2021
Q3 | $70K | Buy |
3,370
+1,350
| +67% | +$28K | ﹤0.01% | 5442 |
|
|
2021
Q2 | $36K | Buy |
2,020
+29
| +1% | +$517 | ﹤0.01% | 5745 |
|
|
2021
Q1 | $49K | Buy |
1,991
+1,482
| +291% | +$36.5K | ﹤0.01% | 5409 |
|
|
2020
Q4 | $17K | Buy |
509
+488
| +2,324% | +$16.3K | ﹤0.01% | 5587 |
|
|
2020
Q3 | $1K | Buy |
+21
| New | +$1K | ﹤0.01% | 5965 |
|